Target intelligence / Profile preview

E3 ubiquitin-protein ligase RNF26 (RNF26)

Target
RNF26
Molecular classification
Enzyme, E3 ubiquitin-protein ligase, RING finger protein, Transmembrane protein
01

Overview

E3 ubiquitin-protein ligase RNF26 is a transmembrane enzyme of the endoplasmic reticulum (ER), characterized by a C3HC5-type RING finger domain and an N-terminal leucine zipper[3][4]. It plays a critical role in the spatial organization of endosomes and perinuclear ER integrity by retaining vesicles in the perinuclear “cloud,” and it mediates ubiquitination of substrates such as SQSTM1/p62 and MITA/STING[1][4][5]. RNF26 acts as a platform for positioning the endosomal system and is involved in antiviral innate immune responses by regulating type I interferon signaling through targeted polyubiquitination of MITA/STING and autophagic degradation of IRF3[5]. It also interacts with cytoskeletal protein vimentin to regulate organelle localization and ER morphology, especially under stress conditions[1]. RNF26 expression is upregulated in various human cancers, suggesting it may contribute to carcinogenesis through dysregulation of its ubiquitination targets[3][4].

Other names
RNF26Ring finger protein 26MGC2642Ring finger protein with leucine zipperE3 ubiquitin-protein ligase RNF26
02

Mechanism of action

Drugs or molecules targeting RNF26 would most likely act by inhibiting or modifying its E3 ligase activity, affecting the ubiquitination of substrates such as SQSTM1/p62 or MITA/STING[5][4].

03

Biological functions

Endosome organizationUbiquitinationOrganelle compartmentalizationType I interferon regulationCell cycle regulationCellular proteostasis
04

Disease associations

CancerRitscher-Schinzel SyndromeInfection (especially viral)Other (ER stress-related disorders)
05

Safety considerations

No direct safety concerns identified, but inhibition may interfere with essential cellular homeostasis, ER organization, immune signaling, and protein quality control[1][5].
06

Biomarkers

Upregulation of RNF26 expression in cancer cell lines (potential biomarker for certain cancers)[3][4].RNF26 expression/activity could potentially serve to monitor ER stress or interferon pathway activity[1][5].

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase RNF26 (RNF26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase RNF26 (RNF26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call